Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 1 1

Status

Completed 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 4

Conditions

Sarcoma 4Solitary Fibrous Tumors 1Sarcoma, Synovial 1Histiocytoma, Malignant Fibrous 1Hemangioendothelioma 1Chondrosarcoma, Mesenchymal 1

Interventions

Doxorubicin 14pembrolizumab 11Specimen Handling 11Magnetic Resonance Spectroscopy 10Biopsy 9Cyclophosphamide 8X-Rays 7Radiotherapy 7Nivolumab 7Ifosfamide 7Phantoms, Imaging 6Gemcitabine 6liposomal doxorubicin 5Temozolomide 5Radiation 5tazemetostat 4palbociclib 4Trabectedin 4Nuclear Medicine Department, Hospital 4Irinotecan 4Ipilimumab 4pazopanib 3larotrectinib 3fludarabine 3cabozantinib 3atezolizumab 3Surveys and Questionnaires 3Radiation Dose Hypofractionation 3Proton Therapy 3Carboplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Sarcoma × Trabectedin × 90 days × Clear all
NCT04383119 2026-03-25

ISG-ARTICLE

Italian Sarcoma Group

Phase 2 Recruiting
100 enrolled
Sarcoma

Sarcoma

NCT01303094 2026-03-16

T-DIS

Centre Oscar Lambret

Phase 2 Completed
53 enrolled
Sarcoma

Sarcoma

NCT04008238 2026-03-06

PIPER

Institut Bergonié

Phase NA Completed
29 enrolled
Sarcoma

Hemangioendothelioma, Sarcoma, Sarcoma, Synovial, Histiocytoma, Malignant Fibrous, Solitary Fibrous Tumors

NCT07444619 2026-03-03

A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas

M.D. Anderson Cancer Center

Phase 1 Not yet recruiting
18 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡